Moderna, Inc. vs Novan
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Moderna, Inc. is the larger company by market value: $90.1 B against $3 M for Novan, 30044 times as much (market caps of Oct 30, 2026 for Moderna, Inc. and Jul 30, 2023 for Novan). Novan's value is the last on file, from Jul 30, 2023: no market-data feed is connected for its exchange yet.
- Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $5 M for Novan in the year to December 2020.
- Both made a net loss: $2.8 B for Moderna, Inc. and $29 M for Novan.
- Moderna, Inc. keeps more of each dollar of sales: a net margin of -145.2% against -595.9% for Novan.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Moderna, Inc. MRNA · #275 in the world | Novan NOVN |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | 2010 | — |
| Size | ||
| Market cap | $90.1 B | $3 M* |
| Revenue | $1.9 B | $5 M |
| Net income | $-2.8 B | $-29 M▲ best |
| Employees | 4,700 | — |
| Valuation | ||
| Price to sales | 35.7× | — |
| Price to book | 10.4× | — |
| Free cash flow yield | -2.3% | — |
| Profitability | ||
| Gross margin | 55.4% | — |
| Operating margin | -158.1% | — |
| Net margin | -145.2% | — |
| Return on equity | -28.9% | — |
| Growth | ||
| Revenue growth | -39.9% | — |
| Revenue growth, 3 years a year | -53.4% | — |
| Financial strength | ||
| Debt to equity | 0.1× | — |
| Cash | ||
| Free cash flow margin | -106.2% | — |
| Shareholder returns | ||
| Shareholder yield | 0.0% | — |
| Strength scores | ||
| Piotroski F-score | 3 of 9 | — |
| Altman Z-score zone | safe | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Jul 2023 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Moderna, Inc. or Novan?
Moderna, Inc. is the larger company by market value: $90.1 B against $3 M for Novan, 30044 times as much (market caps of Oct 30, 2026 for Moderna, Inc. and Jul 30, 2023 for Novan). Novan's value is the last on file, from Jul 30, 2023: no market-data feed is connected for its exchange yet.
Which makes more money, Moderna, Inc. or Novan?
Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $5 M for Novan in the year to December 2020. Both made a net loss: $2.8 B for Moderna, Inc. and $29 M for Novan.
Which is more profitable, Moderna, Inc. or Novan?
Moderna, Inc. keeps more of each dollar of sales: a net margin of -145.2% against -595.9% for Novan.
More about Moderna, Inc.
More about Novan
Sources#
Every figure on this page comes from these, with the date shown next to it.